Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Ritlecitinib shows promise for treating alopecia areata with significant hair regrowth and no serious side effects.

The study created special nanoparticles that effectively deliver an anti-inflammatory drug to treat skin inflammation in psoriasis.

The treatment cleared psoriasis in some patients but caused side effects in most.

Leflunomide with prednisone is effective and well-tolerated for lupus nephritis when cyclophosphamide can't be used.

Ritlecitinib effectively treats alopecia areata and is safe for long-term use in people 12 and older.

Antiviral drugs, especially daclatasvir, may be a new treatment for a rare skin disease, improving survival and reducing symptoms in mice.

Fluridil promotes hair growth safely and effectively for androgenetic alopecia.

Continued ritlecitinib treatment can improve hair regrowth in some alopecia areata patients who initially don't respond.

Vismodegib is effective for basal cell carcinoma but has severe side effects.

Ruxolitinib helps protect skin stem cells and keeps skin healthy in mice with skin GVHD.

Leflunomide successfully treated a rare skin condition in a liver transplant patient.

Repurposing existing drugs can improve cancer treatment but faces challenges.

Ritlecitinib shows promise in improving severe alopecia areata, with 27% of patients seeing success.

Custom software found that common allergy drugs might have new uses for various conditions and could improve survival in some cancers.

The combination of high-dose toremifene and capecitabine was effective for advanced recurrent breast cancer.

The combination therapy is safe and more effective for treating pediatric facial and cervical vitiligo.

Combining low-dose oral minoxidil with immunomodulators shows promise for treating alopecia areata but needs more research.

The choice between belimumab and anifrolumab depends on the specific symptoms of the patient's lupus.

Clofazimine may be effective for treating ashy dermatosis.

Bicalutamide may reduce unwanted hair growth caused by minoxidil in women with hair loss.

Ritlecitinib works well and is safe for treating alopecia areata.

Cemiplimab can cause alopecia areata, but it can be treated successfully.

Tofacitinib and low-dose IL-2 may help maintain hair regrowth in alopecia areata without ongoing treatment.

Pembrolizumab can cause serious liver issues, requiring close monitoring and early treatment.

All four treatments for early rheumatoid arthritis had similar and mostly mild side effects.

Ritlecitinib is the first FDA-approved pill for treating significant hair loss in alopecia areata patients aged 12 and up.

Tigason improved hair growth in a boy with monilethrix without side effects.

Bicalutamide may effectively treat female pattern hair loss with minimal side effects.